Tesamorelin 2 mg
A growth-hormone-releasing-factor analogue.
CAD $42.00 / vial
Vial amount
The specifics, clearly listed.
Product details
Product reference: MRD-0156 Listed amount per vial: 2 mg Sales unit: 1 vial
Read the research in context.
A growth-hormone-releasing-factor analogue.
- EGRIFTA WR — tesamorelin kit: prescribing information — source
Candidate-molecule or reference-product background; not verification of this supplied product.
What this doesn’t establish: The label expressly excludes general weight-loss management and states that long-term cardiovascular safety is not established. WR and SV have formulation-specific differences and are not substitutable according to the label. Branded-product indication, formulation, sterility, storage and authorization cannot be assigned to Meridian from this source. Exact supplied identity/form, measured amount, lot-linked quality reports, purity, sterility/endotoxin, storage/stability and authorization are not established by these references.
Product documents
No verified report is available here for this item. Ask about documentation for Tesamorelin, product reference MRD-0156.
Before you decide.
Separate research about the compound from evidence about the supplied product.
Which vial amount is shown?
This listing shows 2 mg per vial.
Does the study verify this vial?
No. Research on a compound does not establish the identity, quality, safety or effectiveness of a product sold under that name.
What should I check in a report?
Check the sample identity, batch reference, issuer, date, test methods and results. A report applies to the identified sample and tests.
What information should I request?
Ask about the exact product identity, form, specification, handling requirements and relevant batch documents before deciding.